SCI Abstract

search
Defining highly active multiple sclerosis: Survey bias and the interpretation of clinical definitions
Volume 107, March 2026, 106993Author links open overlay panelVihaan SahuShow moreAccess through your organizationCheck acc...
Lack of external validity of the MOG-AR score in a North American cohort
Volume 107, March 2026, 106987Author links open overlay panelMulan Jiang, Anastasia Vishnevetsky, Mattia Wruble Clark, Mon...
AQP4-IgG positive and AQP4-IgG–negative NMOSD: A Multicenter Latin-American Cohort vs. a Single-Center Argentine Cohort
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
Psychological resilience as a dynamic process in relapsing-remitting multiple sclerosis: A response to Alonso and Briggs
Volume 107, March 2026, 106977Author links open overlay panelYunier Broche-Pérez a, Rodneys M. Jiménez-Morales bShow moreA...
A visual reinterpretation of the 2024 McDonald criteria for multiple scleroris
Multiple sclerosis (MS) is the leading disease within the field of neuroimmunology, affecting >2.8 million people world...
Inter-assay variability in anti–JC virus testing for natalizumab: A Spanish cohort
Natalizumab, a humanized monoclonal antibody targeting α4-integrin, is an effective therapy for relapsing–remitting multip...
First demyelinating attack in children: A twelve year single center cohort
Neuroimmune disorders of the central nervous system (CNS) encompass a heterogeneous group of conditions affecting the brai...
Altered serotonergic system and mood behaviors in a cuprizone-induced model of demyelination
Multiple sclerosis (MS) is a disease of the central nervous system (CNS), where demyelination and inflammation lead to axo...
Leg strength and neural activation deficits in older adults with multiple sclerosis
BackgroundMultiple sclerosis (MS) causes immune-mediated inflammation and neurodegeneration in the central nervous system,...
Reduced retinal neuronal injury as a consequence of high efficacy DMT treatment: an OCT study
Optical coherence tomography (OCT) is a non-invasive imaging technique (Huang et al., 1991) that enables the quantificatio...
Profiling peripheral blood oxidative stress in multiple sclerosis
Volume 108, April 2026, 107039Author links open overlay panel, , , , , Highlights•Peripheral blood oxidative stress biomar...
Power production during the five times sit to stand test in people with multiple sclerosis
Multiple sclerosis (MS) is a chronic neurological condition affecting an estimated 2.8 million people worldwide and is a l...
Multiple Sclerosis in the Greenlandic population. A nationwide cohort study
Volume 101, September 2025, 106543Author links open overlay panel, , , , , Highlights•Little is known about the burden of ...
Age of multiple sclerosis symptom onset affects mental and physical health-related quality of life in opposite directions
Katherine M. Sawicka: Writing – review & editing, Writing – original draft, Visualization, Methodology, Investigation,...
Cladribine effects on emotional awareness and reasoning: The CLEAR study
Volume 101, September 2025, 106566Author links open overlay panel, , , , , Highlights•cladribine (Cladribine) is a treatme...
Prevalence of somatic symptom and related disorders at a tertiary neuroimmunology clinic
RESULTS898 patients were referred; 204 (22.7 %) did not have a neuroimmunological disorder. Fifty-four patients (6.0 % of ...
Fingolimod in multiple sclerosis: insights into drug survival and discontinuation factors
Over 300,000 individuals with multiple sclerosis (MS) have received fingolimod treatment (English and Aloi, 2015), (T Ziem...